Search | Page 5 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia

    ... immune therapy. Donors underwent mobilization with cell colony-stimulating factor. The modified preconditioning regimen included ... by the evidence of 100 % donor hematopoiesis ; T lymphocyte subset counts also increased significantly after ...

    Research Article last updated 11/01/2016 - 1:59pm.

  2. Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

    ... L, Harhalakis N, Blijlevens N, Nagler A, Kröger N, de Witte T Original Publication Date:  ... are known to influence the outcome of allogeneic stem cell transplantation (SCT) treatment in myelodysplastic syndromes ...

    Research Article last updated 10/06/2016 - 11:40am.

  3. Pro-inflammatory proteins S100A9 and TNFα suppress erythropoietin elaboration in myelodysplastic syndromes

    ... Primary Author:  Cluzeau T Author(s):  ... has not been investigated. The HepG2 hepatoma cell line was used to investigate in vitro Epo elaboration. Serum collected ...

    Research Article last updated 10/20/2017 - 9:16am.

  4. Symptoms

    ... Low Red Blood Cell Counts A low red blood cell ... seek immediate medical help if they have bleeding that can’t be stopped by usual methods, such as applying pressure to the area. ...

    Topic section last updated 03/10/2016 - 11:00pm.

  5. Symptoms

    ... Low Red Blood Cell Counts A low red blood cell ... seek immediate medical help if they have bleeding that can’t be stopped by usual methods, such as applying pressure to the area. ...

    Topic section last updated 04/19/2016 - 3:34pm.

  6. Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders

    ... phosphate followed by a donor peripheral stem cell transplant in treating patients with myelodysplastic syndromes ... PRA shows > 10% activity, then flow cytometric or B and T cell cytotoxic cross matches should be obtained; the donor should be ...

    Clinical Trial last updated 04/28/2016 - 2:45pm.

  7. Foundation Update - June 2017

    ... June 29, 2017 Thu 1:00 PM EDT Don't miss these archived webinars! > PNH Non-Transplant ... I had six months to live unless I could find a matching stem cell donor. In Korea, where I’m originally from, much less was known about ...

    Article last updated 10/09/2017 - 2:42pm.

  8. Growth Factors

    ... Red Cell Growth Factor Red cell growth ... Factor If you don't have enough healthy white cells in your blood, your doctor may ask you to ...

    Topic section last updated 04/06/2016 - 12:37pm.

  9. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... Background: - Researchers are working to make stem cell transplant procedures safer and more effective. One complication of ... leukocyte count > 100,000/cu mm, karyotypes t(9; 22), t4, t19, t11, biphenotypic leukemia). All second or subsequent ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  10. Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    ... ongoing nonmyeloablative allogeneic peripheral blood stem cell (PBSC) transplant protocol (03-H-0170) for patients with severe ... , which we hypothesize will reduce both the T cells that mediate leukocyte rejection and the B/ plasma cells that ...

    Clinical Trial last updated 04/28/2016 - 9:09am.